Introduction
Corticosteroid injection is a recommended treatment option for carpal tunnel syndrome (CTS), before considering surgery. Nevertheless, the role of injections remains controversial since there is only strong evidence for short-term benefits. The purpose of this study was to determine the re-intervention rate and to identify prognostic indicators for subsequent treatment after a corticosteroid injection for CTS.
Methods
This study evaluated residents of Olmsted County, treated with a corticosteroid injection for CTS between 2001 and 2010. Failure of treatment was the primary outcome of interest. Two definitions for failure were examined: 1) patient receiving subsequent procedural intervention and 2) patient undergoing carpal tunnel release. Survival was estimated using Kaplan-Meier methods and association of covariates with increased failure was modeled using Cox proportional hazards regression.
Results
There were a total of 774 affected hands in 595 patients. The median follow-up period was 7.4 years. Re-intervention was performed in 68% of cases, of which 63% resulted in eventual surgery. Injectate volume was significant for the outcome of any retreatment (hazard ratio (HR) 0.879[0.804–0.96]) and surgery (HR 0.906[0.827–0.99]). Rheumatoid arthritis was also significant in both models, with HR 0.627[0.404–0.97] for any retreatment and HR 0.493[0.292–0.83] for surgery.
Conclusions
In this cohort, 32% of the patients did not receive subsequent treatment after a single injection, which indicates that there is a therapeutic role for corticosteroid injections in the treatment of CTS. Further research is necessary to identify those patients who will benefit from an injection, in order to provide more individually tailored treatment.